Terms: = Head and neck cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA AND Prognosis
5 results:
1. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells.
Grottker F; Gehre S; Reichardt CM; Sengedorj A; Jost T; Rieckmann T; Hecht M; Gostian AO; Frey B; Fietkau R; Gaipl US; Rückert M
Neoplasia; 2023 Nov; 45():100944. PubMed ID: 37857049
[TBL] [Abstract] [Full Text] [Related]
2. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract] [Full Text] [Related]
3. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/hvem axis as a future target for cancer immunotherapy.
Sordo-Bahamonde C; Lorenzo-Herrero S; Granda-Díaz R; Martínez-Pérez A; Aguilar-García C; Rodrigo JP; García-Pedrero JM; Gonzalez S
Mol Cancer; 2023 Aug; 22(1):142. PubMed ID: 37649037
[TBL] [Abstract] [Full Text] [Related]
4. Disruption of Cell-Cell Communication in Anaplastic Thyroid cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract] [Full Text] [Related]
5. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.
Migita K; Sho M; Shimada K; Yasuda S; Yamato I; Takayama T; Matsumoto S; Wakatsuki K; Hotta K; Tanaka T; Ito M; Konishi N; Nakajima Y
Cancer; 2014 Mar; 120(6):808-17. PubMed ID: 24249528
[TBL] [Abstract] [Full Text] [Related]
